These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30324436)

  • 1. CRISPR/Cas9 Gene Editing In Vitro and in Retinal Cells In Vivo.
    Benati D; Marigo V; Recchia A
    Methods Mol Biol; 2019; 1834():59-74. PubMed ID: 30324436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.
    Giannelli SG; Luoni M; Castoldi V; Massimino L; Cabassi T; Angeloni D; Demontis GC; Leocani L; Andreazzoli M; Broccoli V
    Hum Mol Genet; 2018 Mar; 27(5):761-779. PubMed ID: 29281027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.
    Latella MC; Di Salvo MT; Cocchiarella F; Benati D; Grisendi G; Comitato A; Marigo V; Recchia A
    Mol Ther Nucleic Acids; 2016 Nov; 5(11):e389. PubMed ID: 27874856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
    Liu X; Jia R; Meng X; Li Y; Yang L
    Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Dominant and Recessive Forms of Retinitis Pigmentosa by Editing Three Rhodopsin-Encoding Genes in Xenopus Laevis Using Crispr/Cas9.
    Feehan JM; Chiu CN; Stanar P; Tam BM; Ahmed SN; Moritz OL
    Sci Rep; 2017 Jul; 7(1):6920. PubMed ID: 28761125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing with the donor plasmid equipped with synthetic crRNA-target sequence.
    Ishibashi R; Abe K; Ido N; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2020 Aug; 10(1):14120. PubMed ID: 32839482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo.
    Chang H; Yi B; Ma R; Zhang X; Zhao H; Xi Y
    Sci Rep; 2016 Feb; 6():22312. PubMed ID: 26924382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
    Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
    Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Evaluation of Retinal Morphology and Function in Rosa26-Cas9 Knock-In Mice.
    Mohan K; Dubey SK; Jung K; Dubey R; Wang QJ; Prajapati S; Roney J; Abney J; Kleinman ME
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
    Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S
    Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy in
    Wen RH; Stanar P; Tam B; Moritz OL
    Autophagy; 2019 Nov; 15(11):1970-1989. PubMed ID: 30975014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of CRISPR-Cas9 Technology to Reveal Important Aspects of Human Airway Biology.
    Dakhama A; Chu HW
    Methods Mol Biol; 2018; 1799():371-380. PubMed ID: 29956165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
    Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
    Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic Gene Editing of
    McCullough KT; Boye SL; Fajardo D; Calabro K; Peterson JJ; Strang CE; Chakraborty D; Gloskowski S; Haskett S; Samuelsson S; Jiang H; Witherspoon CD; Gamlin PD; Maeder ML; Boye SE
    Hum Gene Ther; 2019 May; 30(5):571-589. PubMed ID: 30358434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E; Eggan K; Merkle FT
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.